Preliminary results from a multicenter, phase II, randomized, noncomparative clinical trial of radiation and temozolomide with or without vandetanib in newly diagnosed glioblastoma (GBM).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 2069-2069
◽
Keyword(s):
Phase Ii
◽
2011 ◽
Vol 81
(2)
◽
pp. S180
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. S45.006-S45.006
2015 ◽
Vol 128
(20)
◽
pp. 2751-2758
◽
2015 ◽
Vol 93
(3)
◽
pp. E88-E89